[Updated treatment of primary pulmonary hypertension -- the role of endothelin receptor antagonists].
Callejas Rubio
J L
JL
Ortego Centeno
N
N
Navarro Pelayo
F
F
Vallejo Rodríguez
I
I
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000077300:Bosentan; D065128:Endothelin Receptor Antagonists; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D007555:Isoxazoles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D007555:Isoxazoles; D013449:Sulfonamides; D013876:Thiophenes; C106276:sitaxsentan; D000077300:Bosentan
Actualización en el tratamiento de la hipertensión pulmonar primaria: papel de los antagonistas de receptores de endotelinas.